Italian pharma company Recordati S.p.A agreed to acquire the global rights to Enjaymo (sutimlimab) from Sanofi SA (NASDAQ:SNY ...

Italian pharma group Recordati said on Friday it would buy from Sanofi the global rights to a drug used to treat cold ...

Bank of America Securities analyst Graham Parry maintained a Buy rating on Sanofi (SNYNF – Research Report) today and set a price target ...

Among the large drugmakers, Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer are worth retaining in one’s portfolio.

Sanofi (SNY) is a stock many investors are watching right now ... The P/S ratio is is calculated as price divided by sales. This is a popular metric because sales are harder to manipulate on an income ...

The FDA approved Regeneron and Sanofi's Dupixent as an add-on treatment for inadequately controlled COPD, demonstrating ...

The Sanofi Consumer Healthcare India Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹5037.8 today. What is the Market Cap of Sanofi Consumer Healthcare India Ltd? Market capitalization ...

Novavax (NVAX) shares climbed 15% Wednesday after Jefferies released a bullish note on the company’s prospects after meeting ...